Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
03/10/1998 | US5726164 Nanosuspensions for intravenous administration |
03/10/1998 | US5724995 Method for screening factors on a paralysis model and method for obtaining this model |
03/10/1998 | CA2043136C N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
03/05/1998 | WO1998008966A1 Loxoprofen-containing preparation for external use |
03/05/1998 | WO1998008965A2 Cd95 regulatory gene sequences and transcription factors |
03/05/1998 | WO1998008868A1 MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS |
03/05/1998 | WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
03/05/1998 | WO1998008850A1 Spirocyclic metalloprotease inhibitors |
03/05/1998 | WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives |
03/05/1998 | WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives |
03/05/1998 | WO1998008843A1 4-aminoethoxy-indolone derivatives as dopamine d2 agonists |
03/05/1998 | WO1998008835A1 Spirocyclic dopamine receptor subtype ligands |
03/05/1998 | WO1998008834A1 Benzylamine derivatives, their preparation and their application in therapeutics |
03/05/1998 | WO1998008826A1 Piperazino derivatives as neurokinin antagonists |
03/05/1998 | WO1998008819A1 4-aminoethoxy indolone derivatives |
03/05/1998 | WO1998008817A1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands |
03/05/1998 | WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist |
03/05/1998 | WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist |
03/05/1998 | WO1998008508A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections |
03/05/1998 | WO1998008503A1 Therapeutic methods and compositions involving isoflavones |
03/05/1998 | WO1998008502A1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b]BENZOFURANS |
03/05/1998 | WO1998008501A1 Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia |
03/05/1998 | WO1998008498A1 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants |
03/05/1998 | WO1998008497A1 Sulfonyl fluorides for the treatment of alzheimer's disease |
03/05/1998 | WO1998008495A1 Galenic formula with extended release of milnacipran |
03/05/1998 | WO1998002452A3 Compounds and methods for modulating cell adhesion |
03/05/1998 | WO1998001554A3 Secreted proteins and polynucleotides encoding them |
03/05/1998 | WO1998001552A3 Secreted proteins and polynucleotides encoding them |
03/05/1998 | WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
03/05/1998 | CA2265049A1 Therapeutic methods and compositions involving isoflavones |
03/05/1998 | CA2264577A1 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants |
03/05/1998 | CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist |
03/05/1998 | CA2264267A1 Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta¬b|benzofurans |
03/05/1998 | CA2264080A1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands |
03/05/1998 | CA2264078A1 4-aminoethoxy indolone derivatives |
03/05/1998 | CA2264072A1 4-aminoethoxy-indolone derivatives as dopamine d2 agonists |
03/05/1998 | CA2264044A1 Spirocyclic metalloprotease inhibitors |
03/05/1998 | CA2263839A1 Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia |
03/05/1998 | CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use |
03/05/1998 | CA2263824A1 Cd95 regulatory gene sequences and transcription factors |
03/05/1998 | CA2263499A1 Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection |
03/05/1998 | CA2263161A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections |
03/05/1998 | CA2262453A1 Modulators of .beta.-amyloid peptide aggregation comprising d-amino acids |
03/04/1998 | EP0826685A1 Stable, long acting salts of carboxamides for the treatment of joint disease |
03/04/1998 | EP0826676A1 Oxazole derivatives and use thereof |
03/04/1998 | EP0826673A1 Acetamide derivatives, process for producing the same, and medicinal composition containing the same |
03/04/1998 | EP0826663A2 Alkynylamino acid derivatives and their use as pharmaceutical compounds |
03/04/1998 | EP0826374A2 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
03/04/1998 | EP0826051A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
03/04/1998 | EP0826042A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
03/04/1998 | EP0826041A1 Transforming growth factor alpha hii |
03/04/1998 | EP0826035A1 Isolating and culturing schwann cells |
03/04/1998 | EP0826000A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses |
03/04/1998 | EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
03/04/1998 | EP0825993A1 Xanthines and their therapeutic use |
03/04/1998 | EP0825991A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists |
03/04/1998 | EP0825984A1 Novel method |
03/04/1998 | EP0825981A1 Novel heterocyclic compounds |
03/04/1998 | EP0825859A1 Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction |
03/04/1998 | EP0825857A1 A method of treatment of mania and bipolar disorder |
03/04/1998 | EP0692962B1 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses |
03/04/1998 | EP0625988A4 Allosteric modulators of the nmda receptor. |
03/04/1998 | CN1175262A Novel receptor |
03/04/1998 | CN1175256A Tetracyclic spiro compounds, process for their preparation and their use as 5 HT1D receptor antagonists |
03/04/1998 | CN1175246A Substituted azetidin-2-ones for treatment of atherosclerosis |
03/04/1998 | CN1174833A Phenyl substituted alkenocarboxylic guanidine, preparation method, application as medicine or diagnostic agent adn medicine containing it |
03/03/1998 | US5723668 Method of separating the racemate of tramadol |
03/03/1998 | US5723614 Piperazinyl-substituted, treating tension, deparssion and psychoses |
03/03/1998 | US5723608 3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands |
03/03/1998 | US5723589 Nonglycoside linkage |
03/03/1998 | US5723575 Process for the preparation of backbone cyclic peptides |
03/03/1998 | US5723494 Derivatives of glutamic and aspartic acids, a method of preparing them, and their use as drugs for enhancing memory and learning |
03/03/1998 | US5723489 Aryloxypropanolamine beta 3 adrenergic agonists |
03/03/1998 | US5723485 Analgesic, antiinflammatory agents |
03/03/1998 | US5723484 Benzopyran compounds as 5-HT2C receptor antagonists |
03/03/1998 | US5723483 Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors, their preparation and pharmaceutical compositions containing them |
03/03/1998 | US5723472 Aminobenzoic acid derivatives |
03/03/1998 | US5723467 Method of treating psychotic disorders using risperidone pamoate |
03/03/1998 | US5723464 Piperazine derivatives |
03/03/1998 | US5723449 Antisecretory agents and anticarcinogenic agents |
03/03/1998 | US5723444 Enzyme inhibitors and anticoagulants |
03/03/1998 | US5723315 Secreted proteins and polynucleotides encoding them |
03/03/1998 | US5723290 Methods for profiling mRNA expression in neurites |
02/28/1998 | CA2212954A1 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
02/27/1998 | CA2213893A1 Pharmaceutical compounds |
02/26/1998 | WO1998007859A2 Secreted proteins and polynucleotides encoding them |
02/26/1998 | WO1998007854A1 Human glycine transporter |
02/26/1998 | WO1998007853A1 Secreted proteins and polynucleotides encoding them |
02/26/1998 | WO1998007850A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
02/26/1998 | WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
02/26/1998 | WO1998007718A1 Non-peptide bombesin receptor antagonists |
02/26/1998 | WO1998007711A1 Troponyl piperazines as selective dopamine d4 receptor ligands |
02/26/1998 | WO1998007710A1 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists |
02/26/1998 | WO1998007704A1 Tetrahydroquinoline derivatives as eaa antagonists |
02/26/1998 | WO1998007694A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
02/26/1998 | WO1998007692A1 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors |
02/26/1998 | WO1998007431A1 Cholinesterase inhibitors for treatment of parkinson's disease |
02/26/1998 | WO1998007427A1 Cocaine receptor binding ligands |
02/26/1998 | WO1998007426A1 Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes |
02/26/1998 | WO1998007420A1 Neuropeptide-y ligands |